Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants
Apply
VX-201
Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step